Ophthalmology · Bogalusa, LA
NPI
1629267893
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
433 Plaza St Rm 213
Bogalusa, LA, 70427
Phone (985) 730-7209
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
618 services
Medicare patients, 2024
230
Average age 75
Drug cost, 2024
$469K
1,578 prescriptions
Company payments, 2025
$506
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria D Bernal was code 99213 (office e&m - established), 277 times for 150 patients. In total Maria D Bernal billed 618 services in 32 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 277 | 150 | $61.59 | $17K |
| 99214 Office E&M - Established | Office | 76 | 67 | $85.40 | $6,491 |
| 76514 Ultrasound - Nonspecific | Office | 65 | 37 | $7.89 | $513 |
| 92201 Ophthalmological E&M | Office | 41 | 38 | $15.61 | $640 |
| 99204 Office E&M - New | Office | 20 | 20 | $102.56 | $2,051 |
By year: 2022 $55K for 754 services; 2023 $54K for 741 services; 2024 $45K for 618 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria D Bernal prescribed most often to Medicare patients was Prednisolone Acetate, with 242 prescriptions and refills. In total Maria D Bernal wrote 1,578 Medicare prescriptions that cost $469K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 242 | 360 | 110 | $11K |
| Restasis Cyclosporine | 120 | 158 | 48 | $92K |
| Valacyclovir Valacyclovir Hcl | 109 | 190 | 29 | $6,063 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 88 | 198 | 37 | $1,130 |
| Moxifloxacin Moxifloxacin Hcl | 71 | 71 | 19 | $1,867 |
| Timolol Maleate Generic | 64 | 142 | 22 | $420 |
| Ilevro Nepafenac | 63 | 82 | 25 | $24K |
| Atropine Sulfate Generic | 58 | 69 | 17 | $2,058 |
| Difluprednate Generic | 53 | 61 | Under 11 | $5,985 |
| Latanoprost Generic | 50 | 98 | 19 | $400 |
| Xiidra Lifitegrast | 44 | 62 | 14 | $42K |
| Dorzolamide Hcl Generic | 42 | 67 | 12 | $682 |
| Tyrvaya Varenicline Tartrate | 36 | 50 | Under 11 | $33K |
| Brimonidine Tartrate Generic | 36 | 61 | 12 | $114 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 36 | 49 | 28 | $304 |
Brand drugs: 796 claims; generic drugs: 782 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria D Bernal $506 ($506 in general payments such as food, travel and fees) from 7 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $154.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 6 | $154 |
| Alcon Vision LLC ALC | 4 | $98.63 |
| Glaukos Corporation GKOS | 1 | $93.2 |
| Dompe US, Inc. | 3 | $84.24 |
| Biotissue Holdings Inc. | 1 | $27.75 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $26.39 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $21.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.